Page 2 - Mauro Maccarrone News Today : Breaking News, Live Updates & Top Stories | Vimarsana

InMed Announces Publication of Peer-Reviewed Study Showing the Anti-Inflammatory Potential of Rare Cannabinoids in Skin Conditions

InMed Announces Publication of Peer-Reviewed Study Showing the Anti-Inflammatory Potential of Rare Cannabinoids in Skin Conditions
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomBritish columbiaEric hsuMauro maccarroneColin clancyDepartment of biotechnologicalInmed pharmaceuticalsBritish columbia newsfile corpClinical sciencesPreclinical researchExchange commissionInternational journal of molecular sciencesCorporate communicationsInmed pharmaceuticals incMed pharmaceuticalsInternational journal

InMed (INM) Announces Publication of Peer-Reviewed Study Showing the Anti-Inflammatory Potential of Rare Cannabinoids in Skin Conditions

InMed (INM) Announces Publication of Peer-Reviewed Study Showing the Anti-Inflammatory Potential of Rare Cannabinoids in Skin Conditions
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Eric hsuMauro maccarroneDepartment of biotechnologicalInternational journal of molecular sciencesClinical sciencesPreclinical researchInmed pharmaceuticals incMed pharmaceuticalsInternational journalApplied clinical sciences

InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update

InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomBritish columbiaMauro maccarroneColin clancyMichael woudenbergErica adamsRadicle science incInmed pharmaceuticalsDepartment of biotechnologicalCompany phaseCompany nasdaqDrug administrationData monitoring committeeClinical sciencesExchange commission

InMed Announces Publication of Peer-Reviewed Study Highlighting Potential Role of Rare Cannabinoids THCV, CBC and others on Skin Conditions

InMed Announces Publication of Peer-Reviewed Study Highlighting Potential Role of Rare Cannabinoids THCV, CBC and others on Skin Conditions - read this article along with other careers information, tips and advice on BioSpace

United kingdomBritish columbiaEric hsuMauro maccarroneColin clancyDepartment of biotechnologicalInmed pharmaceuticalsCompany nasdaqClinical sciencesPreclinical researchExchange commissionInternational journal of molecular sciencesInmed pharmaceuticals incInvestor relations corporate communicationsMed pharmaceuticalsRare phytocannabinoids

InMed Announces Publication of Peer-Reviewed Study

VANCOUVER, British Columbia, June 14, 2022 (GLOBE NEWSWIRE) InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the.

United kingdomBritish columbiaEric hsuMauro maccarroneColin clancyDepartment of biotechnologicalInmed pharmaceuticalsCompany nasdaqClinical sciencesPreclinical researchExchange commissionInternational journal of molecular sciencesInmed pharmaceuticals incInvestor relations corporate communicationsMed pharmaceuticalsRare phytocannabinoids